NCT00952783

A Long Term Follow up Study of Patients Who Have Completed the PEP005-020 Study

A 12 Month, Long-term Follow-up Study of Patients With Actinic Keratosis on Non-head Areas (Trunk and Extremities) Who Have Completed Day 57 in Study PEP005-020

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 98 (actual)
• Sponsor: Peplin · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This study is designed to follow up patients, who have achieved complete clearance of AK lesions (lesion count of 0) at Day 57 in the PEP005-020 study, over a 12 month period to assess both recurrence of Actinic Keratosis (AK) lesions and long term safety in the selected treatment area.

Conditions

• Actinic Keratosis

Interventions

Type	Name	Description
DRUG	Lesion count	Lesion count in area treated by study drug in a prior study over a 12 month period No drug will be applied during this long-term follow up study. Drug was applied during the primary study.

Timeline

• Start date: 2009-07-01
• Primary completion: 2010-10-01
• Completion: 2010-10-01
• First posted: 2009-08-06
• Last updated: 2015-03-26

Locations

11 sites across 2 countries: United States, Australia